- Home
- ORGO vs CHW Comparison
ORGO vs CHW Comparison
Compare ORGO & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- CHW
- Stock Information
- Founded
- ORGO 1985
- CHW 2007
- Country
- ORGO United States
- CHW United States
- Employees
- ORGO N/A
- CHW N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- CHW Investment Managers
- Sector
- ORGO Health Care
- CHW Finance
- Exchange
- ORGO Nasdaq
- CHW Nasdaq
- Market Cap
- ORGO 418.7M
- CHW 431.1M
- IPO Year
- ORGO N/A
- CHW N/A
- Fundamental
- Price
- ORGO $3.34
- CHW $6.83
- Analyst Decision
- ORGO Strong Buy
- CHW
- Analyst Count
- ORGO 2
- CHW 0
- Target Price
- ORGO $5.00
- CHW N/A
- AVG Volume (30 Days)
- ORGO 607.1K
- CHW 195.2K
- Earning Date
- ORGO 02-27-2025
- CHW 01-01-0001
- Dividend Yield
- ORGO N/A
- CHW 9.27%
- EPS Growth
- ORGO N/A
- CHW N/A
- EPS
- ORGO N/A
- CHW N/A
- Revenue
- ORGO $455,038,000.00
- CHW N/A
- Revenue This Year
- ORGO $9.65
- CHW N/A
- Revenue Next Year
- ORGO $1.57
- CHW N/A
- P/E Ratio
- ORGO N/A
- CHW N/A
- Revenue Growth
- ORGO 1.34
- CHW N/A
- 52 Week Low
- ORGO $2.17
- CHW $5.07
- 52 Week High
- ORGO $4.57
- CHW $6.54
- Technical
- Relative Strength Index (RSI)
- ORGO 53.23
- CHW 48.22
- Support Level
- ORGO $2.88
- CHW $6.64
- Resistance Level
- ORGO $3.24
- CHW $6.81
- Average True Range (ATR)
- ORGO 0.16
- CHW 0.10
- MACD
- ORGO 0.04
- CHW 0.01
- Stochastic Oscillator
- ORGO 90.29
- CHW 46.34
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment strategy is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.